Related by context. All words. (Click for frequent words.) 69 radiation chemoradiation 66 metastatic neuroendocrine tumors 65 Shark cartilage 65 cisplatin chemotherapy 65 Basal cell 65 deCODE BreastCancer 65 Squamous 65 Uveal melanoma 65 bronchogenic carcinoma 65 metastatic gastric 64 papillary renal cell carcinoma 64 epithelial tumors 64 recurrent metastatic 64 LRP5 64 antitumor effect 64 underarm lymph nodes 64 renal carcinoma 64 BEXXAR Therapeutic Regimen 64 GRNOPC1 contains 64 insulin secreting beta 64 potent inducer 64 mutated K ras 64 Radical prostatectomy 63 proliferative disorders 63 cytoreduction 63 HER2 neu 63 Chronic pancreatitis 63 CYT# potent vascular disrupting 63 pancreatic adenocarcinoma 63 Chronic lymphocytic leukemia 63 Acute myeloid leukemia 63 kidney urologic 63 Glioblastoma multiforme GBM 63 differentiated thyroid 63 deCODE ProstateCancer TM 63 histologic subtype 63 squamous cell lung cancer 63 operable breast cancer 63 postoperative chemotherapy 63 Metastatic breast cancer 63 Hepatocellular Carcinoma HCC 63 tumor histology 63 Medullary thyroid cancer 63 recurrent metastatic ovarian cancer 63 liver metastasis 63 metastatic bladder 63 cytoreductive surgery 62 Platinol ® cisplatin 62 Metastatic prostate cancer 62 Radiofrequency ablation 62 clinico pathological 62 antiangiogenic agent 62 NPM1 mutation 62 K ras mutations 62 preoperative chemotherapy 62 cervical carcinoma 62 pain palliation 62 Malignant glioma 62 Glioblastoma multiforme 62 hypermethylated 62 PCNSL 62 myelofibrosis polycythemia vera 62 cytolytic 62 HER2 expression 62 percutaneous biopsy 62 antiangiogenic therapy 62 tamoxifen Nolvadex ® 62 metastatic lymph nodes 62 ERBITUX Cetuximab 62 nonsmall cell lung cancer 62 unresectable tumors 62 Endometrial cancer 62 OnDose TM 62 cisplatin resistant 62 YONDELIS 62 prostate carcinomas 62 Adjuvant chemotherapy 62 colorectal adenocarcinoma 62 mesenchymal cell 62 ovarian endometrial 62 HER2 positivity 62 Surgical resection 62 Xelox 62 lymph node enlargement 62 KRAS status 62 Temsirolimus 62 axillary dissection 62 oligodendrogliomas 62 Circulating tumor cells 61 deCODE BreastCancer TM 61 pancreatic ductal 61 recurrent glioblastoma multiforme 61 malignant pleural mesothelioma 61 diagnose coronary artery 61 cervical lymph node 61 indibulin 61 TTF therapy 61 localized prostate 61 HER2 overexpression 61 Stereotactic radiosurgery 61 cervical prostate 61 allogeneic HSCT 61 ovarian pancreatic 61 tumor subtypes 61 lung pancreatic 61 relapsing remitting MS RRMS 61 TRAIL induced apoptosis 61 radiochemotherapy 61 ANCA associated 61 skeletal metastases 61 PI3K AKT 61 chemoresistant 61 PSMA ADC 61 pelvic malignancies 61 metastatic colorectal 61 KRAS mutant 61 MGd 61 radiolabeled TM# 61 cisplatin gemcitabine 61 prophylactic cranial irradiation 61 Lymph node 61 sentinel lymph node biopsy 61 gastrointestinal stromal tumors GISTs 61 pancreatic prostate 61 HER2 receptor 61 spontaneous regression 61 hypervascular tumors 61 Iodine counteracts 61 Like Waitz Aanesen 61 prognostic marker 61 chimeric monoclonal antibody 61 histological subtype 61 CMV infections 61 neoadjuvant therapy 61 malignant pancreatic 61 chemotherapy cisplatin 61 carcinoids 61 doxorubicin Adriamycin 61 locoregional recurrence 61 SSc 61 Sentinel node biopsy 61 cirrhosis liver failure 61 Hurthle cell 61 Chronic lymphocytic leukemia CLL 61 phenotypic expression 61 nonmelanoma 61 ADVEXIN therapy 61 malignant cancerous 60 Aplidin 60 hematopoietic cancers 60 Adjuvant therapy 60 cervical lymph nodes 60 gynecologic malignancy 60 Systemic lupus erythematosus 60 malignant neoplasm 60 advanced metastatic prostate 60 EGFR mutation positive 60 tumor metastases 60 paclitaxel poliglumex 60 Liver transplantation 60 sarcomatoid 60 lymphatic tissue 60 KRAS oncogene 60 adjuvant systemic 60 locoregional 60 molecular abnormalities 60 biliary tract cancer 60 visit www.rtanswers.org 60 Lung transplantation 60 recurrent ovarian 60 K ras gene 60 DNA methylation patterns 60 Squamous cell 60 Genetic variants 60 Allovectin 7 ® 60 hormone receptor negative 60 transgene expression 60 Colon polyps 60 cytolytic activity 60 Smac mimetic 60 etiologic 60 Polycythemia vera 60 Xanafide 60 sporadic Creutzfeldt Jakob 60 Study Tanning beds 60 thromboembolic disease 60 radionuclide therapy 60 Epstein Barr Virus EBV 60 solar keratosis 60 breast cancer subtypes 60 thymidylate synthase TS 60 lymphangiogenesis 60 erlotinib Tarceva ® 60 esophagogastric 60 lymphomas leukemias 60 TMPRSS2 ERG fusion 60 temozolomide TMZ 60 Benign tumors 60 lung epithelium 60 Epstein Barr virus EBV 60 stage IIIA 60 immune dysregulation 60 ixabepilone 60 histologies 60 diabetic kidney 60 gastric adenocarcinoma 60 p# biomarker 60 basal epithelial 60 Uterine cancer 60 vinca alkaloid 60 radiolabeled antibodies 60 haematopoietic 60 Brain metastases 60 peritoneal cancer 60 PARP inhibition 60 nonmelanoma skin cancers 60 commercialize deforolimus 60 chemotherapeutic regimen 60 carcinoma HCC 60 hormone receptor status 60 urothelial cancer 60 renal cell carcinomas 60 Papillary 60 Transverse myelitis 60 mucinous 60 MAGE A3 ASCI 60 upregulating 60 thalidomide Thalomid 60 virotherapy 60 fusion enhancers 60 angiogenesis inhibition 60 ADAMTS# 60 Arsenic trioxide 60 allogeneic bone marrow 60 leiomyoma 59 gemcitabine chemotherapy 59 leiomyomas 59 EndoTAGTM 1 59 eribulin mesylate 59 nodal metastasis 59 Mitomycin C 59 rituximab Rituxan 59 metastatic pancreatic 59 Bleomycin 59 chemosensitivity 59 etiological agent 59 pancreatic lung 59 Sezary syndrome 59 lenalidomide dexamethasone 59 gastrointestinal stromal 59 ADPKD 59 breast carcinomas 59 Glioma 59 EGFr expressing metastatic colorectal 59 KRAS mutation 59 promoter hypermethylation 59 Cathepsin B 59 androgen receptor AR 59 HuCNS SC ® 59 Latent TB 59 fibrosarcoma 59 Relapsing remitting MS 59 Bezielle 59 immune modulator 59 Ribavirin causes 59 prostate carcinoma 59 anti angiogenic therapy 59 Estrogen receptor positive 59 HG PIN 59 Pulmonary fibrosis 59 genetic aberrations 59 colorectum 59 gastric cardia 59 node metastases 59 tumoral 59 Malignant mesothelioma 59 Rectal cancer 59 precursor lesions 59 oral clodronate 59 KRAS variant 59 survivin expression 59 ToGA 59 molecular biomarkers 59 detecting coronary artery 59 hormonally sensitive 59 peritoneal carcinomatosis 59 intraperitoneal therapy 59 idiopathic pulmonary 59 complement inhibitor eculizumab 59 LungAlert TM 59 hormone deprivation 59 novel emulsion formulation 59 malignant pleural mesothelioma MPM 59 thyroid nodule 59 severe congenital neutropenia 59 haematologic 59 metastatic liver 59 viral nucleic acids 59 nonmetastatic 59 chemo immunotherapy 59 FUS protein 59 Prognostic factors 59 anaplastic 59 surgical debulking 59 refractory Hodgkin 59 Lupus nephritis 59 Colorectal cancer CRC 59 Umbilical cord stem cells 59 fibrotic disease 59 Stereotactic body 59 gemcitabine Gemzar ® 59 Akt activation 59 Interferon beta 59 prognostic indicator 59 concurrent chemoradiation 59 hypoxic tumor 59 Leukemias 59 bortezomib Velcade 59 advanced hepatocellular carcinoma 59 sorafenib tablets 59 Vidaza azacitidine 59 chronic myeloid 59 chronic hepatitis cirrhosis 59 serous ovarian cancer 59 Glioblastoma Multiforme GBM 59 ovarian lung 59 submandibular gland 59 relapsed leukemia 59 genomic rearrangement 59 Thalomid ® 59 gene amplification 59 multifactorial disease 59 pelvic lymph nodes 59 gemcitabine Gemzar 59 lymphoma multiple myeloma 59 refractory chronic lymphocytic 59 neoplastic cells 59 Hutchinson Gilford progeria 59 neuroendocrine cancers 59 hormone refractory 59 anti angiogenic agents 59 tNOX 59 intra arterial chemotherapy 59 endometrial hyperplasia 59 seminoma 59 mTOR inhibition 59 System IPSS 59 RECAF tm 59 invasive fungal 59 NMIBC 59 chromosomal mutations 59 BCG refractory 59 axillary lymph node 59 HIV tropism 59 breast endometrial 59 Bayer HealthCare Onyx Pharmaceuticals 59 EGFR receptor 59 fallopian tube carcinoma 59 nutlin 3a 59 immune modulating 59 PROCHYMAL 59 pancreatic islet cell 59 squamous cell carcinoma SCC 59 myelomas 59 treat chronic sinusitis 59 Human papillomavirus 59 Aggrastat ® tirofiban hydrochloride 59 transarterial 59 colorectal lung 59 R sorafenib tablets 59 endocrine therapies 59 neovascularisation 59 ductal adenocarcinoma 59 Follicular lymphoma 59 pancreatic islet beta 58 B7 H3 58 accumulate preferentially 58 carcinomatosis 58 oral squamous cell 58 pediatric malignancies 58 antiangiogenic agents 58 gefitinib Iressa 58 mutated p# 58 HER2 positive breast 58 mitogen activated protein kinases 58 Gleevec resistant 58 ALA PDT 58 kidney fibrosis 58 adjuvant radiation 58 distant metastasis 58 HuLuc# 58 Panzem R NCD 58 Diabetic nephropathy 58 infectious prion proteins 58 Chronic myeloid leukemia CML 58 nonnucleoside reverse transcriptase inhibitors 58 immunosuppressive regimens 58 polyomavirus nephropathy 58 FOLFOX chemotherapy 58 methylation markers 58 gastric carcinoma 58 chlamydial infection 58 choroidal melanoma 58 clinically detectable 58 viral tropism 58 pre cancerous actinic 58 ductal carcinomas 58 Intravenous immunoglobulin 58 transfusion syndrome 58 paclitaxel Taxol ® 58 treating cancerous tumors 58 hereditary predisposition 58 alkylating agent 58 Androgen deprivation therapy 58 Benign breast 58 pituitary adenomas 58 biologic pathways 58 membranous nephropathy 58 metastatic renal 58 neratinib 58 Basal cell carcinoma 58 metastatic carcinoma 58 choroidal vasculopathy 58 taxane chemotherapy administered 58 prostate cancer PCa 58 tumorigenicity 58 Pemetrexed 58 Non Hodgkins lymphoma 58 primary humoral immunodeficiency 58 poloxamer 58 aT cell 58 Genetic mutation 58 lung esophageal 58 esophageal squamous cell carcinoma 58 colonic mucosa 58 colorectal carcinoma 58 MYLOTARG 58 inflammatory demyelinating 58 sonographic diagnosis 58 grade serous ovarian 58 BRCA1 BRCA2 58 Fludara ® 58 Ceplene/IL-2 58 anti tumoral 58 metastatic HER2 negative 58 FDG PET imaging 58 BRAF gene 58 astrocytomas 58 Peripheral nerves 58 lung cancer NSCLC 58 nonvascular 58 Pleural mesothelioma 58 carcinoid tumors 58 hamartomas 58 chromosomal aberrations 58 acute leukemias 58 dirucotide MBP# 58 antiproliferative effects 58 Carcinoid tumors 58 Darinaparsin 58 XYOTAX TM 58 pegylated IFN 58 Panzem NCD 58 multi factorial disease 58 patients undergoing chemotherapy 58 fibrate drugs 58 lymphatic mapping 58 albumin bound paclitaxel 58 substantially excreted 58 RRM1 58 oncogenic transformation 58 micrometastasis 58 Surgical excision 58 metastatic ovarian cancer 58 refractory prostate cancer 58 poly ADP ribose polymerase 58 lupus renal disease 58 taxane chemotherapy 58 non hodgkin lymphoma 58 BRAF inhibitors 58 hepatocellular carcinoma liver 58 IMiDs ® compound 58 recurrent NSCLC 58 metastatic prostate 58 Immunosuppressive drugs 58 GIST tumors 58 Mammosite 58 Gliomas 58 hematopoietic cell 58 radiosensitive 58 basal cell carcinoma squamous 58 SETDB1 58 tumor excision 58 Autoimmune hepatitis 58 BRAF V#E mutation 58 Cojocaru correspondent 58 Chronic myeloid leukemia 58 BRCA deficient 58 NSAID induced GI 58 hepatocellular carcinoma 58 precancerous condition 58 Heavy menstrual bleeding 58 Angiolix 58 hepatocellular liver 58 latent tuberculosis TB 58 mutational status 58 ATG#L# 58 acadesine 58 Alpha lipoic acid 58 intra abdominal infections 58 BRCA mutation carriers 58 benign prostatic hyperplasia enlarged 58 bladder cervix 58 hepatocellular carcinomas 58 Sporadic CJD 58 metastatic malignant 58 IDH mutations 58 Vidaza ® 58 STAT3 signaling 58 HuMax EGFr 58 Hepatocellular carcinoma 58 neoplastic diseases 58 TRIOLEX HE# APOPTONE HE# 58 endometrial ovarian 58 relapsed MM 58 Her2 positive 58 bone metastasis 58 Idiopathic pulmonary fibrosis 58 Hair follicle 58 clinicopathologic 58 lymph node removal 58 mTOR inhibitors 58 cytoprotective 58 Candida infection 58 PrevOnco ™ 58 Metastatic 58 antiestrogen therapy 58 systemic ALCL 58 PIK3CA 58 Ectopic pregnancy 58 Tarvacin 58 IMiDs 58 anticancer therapy 58 non mutated KRAS 58 peptide antigens 58 NSCLC tumors 58 pancreatic endocrine 58 esthesioneuroblastoma rare form 58 CYP#D# gene 58 Transdrug R 58 taxane therapy 58 metastatic lesions 58 Venous thromboembolism 58 pilocytic astrocytomas 58 diagnostic biomarker 58 novel VDA molecule 58 ELACYT 58 colorectal adenoma 58 cancer metastasizes 58 Gastric cancer 58 seminomas 58 Pelvic inflammatory 58 Cytoxan 58 oral deforolimus 58 malignant prostate 58 GPC5 58 NKX#.# 58 Chronic sinusitis 58 neoadjuvant 58 recurrent glioblastoma multiforme GBM 58 cyclic AMP cAMP 58 OHR/AVR# 58 invasive lobular 58 cutaneous squamous cell carcinoma 58 esophagogastric junction 58 papillary carcinoma 58 non resectable metastatic 58 untreated metastatic melanoma 58 membranous nephritis 58 potent suppressor 58 Cryptococcus neoformans 58 metastatic uveal melanoma 58 nonsquamous 58 intercellular signaling 58 multiple myeloma MM 58 follicular Non Hodgkin 58 advanced SCCHN 58 Vandetanib 58 invasive lobular carcinoma 58 demonstrated antitumor activity 58 HbF 58 Poly ICLC 58 small lymphocytic lymphoma 58 anti angiogenic drugs 58 microRNA biomarkers 58 pancreatic carcinoma 58 malignant growths 58 potent antiproliferative 58 sirtuin activators 58 genomic alterations 58 EGFR mutant 58 pre malignant lesions 58 ERK signaling 58 clinicopathological 58 either acutely decompensated 57 solar keratoses 57 lung metastasis 57 androgen suppression 57 potentially hepatotoxic 57 cancerdefine 57 POTELLIGENT ® Technology 57 NF kB signaling 57 pharmacologic stress 57 histone acetylation 57 letrozole Femara 57 Pulmonary arterial hypertension 57 Hodgkin lymphoma HL 57 atherothrombotic disease 57 MCF7 57 somatostatin receptors 57 invasive carcinoma 57 B7 H4 57 anastrazole 57 curative therapy 57 metastatic GIST 57 MALT lymphoma 57 lymphoid tumors 57 hepatoma 57 Darapladib 57 Chlamydia psittaci 57 pleural mesothelioma 57 bladder tumors 57 rhITF 57 Meningiomas 57 protein tyrosine phosphatase 57 CCR5 co 57 Inhaling asbestos fibers 57 Tr DNA 57 chemoembolization 57 cytotoxic therapies 57 mertansine 57 Li Fraumeni 57 axillary nodes 57 microRNA profiling 57 Fc gamma receptor 57 prostate cancer CaP 57 completely resected 57 gemcitabine carboplatin 57 curative resection 57 gene rearrangements 57 LHRH antagonists 57 riociguat 57 treating sarcoma testicular 57 Ovary removal 57 proton MR spectroscopy 57 MIF protein 57 cT3 prostate cancer 57 urothelial carcinoma 57 chemo resistant 57 prostate carcinogenesis 57 simplex virus 57 relapsed SCLC 57 sapacitabine CYC# 57 micrometastases 57 myeloproliferative diseases 57 intratumoral 57 monogenic 57 HepaMate ™ 57 tongue mouth pharynx 57 Telintra 57 ductal breast cancer 57 commercializes oncology 57 inherited mutations 57 TMEM 57 PRESEPT study 57 FUSILEV enhances 57 prostatic tissue 57 mutated KRAS gene 57 Stat5 57 herpesviruses 57 metachronous 57 ovarian suppression 57 Nicole Onetto MD 57 Neuropathic pain 57 HuMax TAC 57 humanised antibody 57 Waldenstrom macroglobulinemia 57 Retrograde ejaculation 57 recombinant interferon 57 FGFs 57 pleiotropic 57 Molecular imaging 57 HNSCC 57 ChromoCure develops 57 Balamuthia 57 targeted radiotherapeutic 57 BRAF mutated 57 postoperative radiotherapy 57 Fibroblast 57 Gemzar ® 57 pediatric acute lymphoblastic 57 antibody mediated 57 Vorinostat 57 Hemopurifier TM 57 progressive metastatic prostate 57 oral mTOR inhibitor 57 Oxidative damage 57 recurrent malignant glioma 57 alpha fetoprotein AFP 57 intravenous iv 57 LHRH receptor positive 57 TMEM density 57 TNFerade TM 57 Sanofi Aventis Taxotere 57 flavopiridol 57 Peritoneal mesothelioma 57 intestinal mucosal 57 lung adenocarcinomas 57 JAK2 enzyme 57 refractory acute myeloid 57 leukemia myeloma 57 Lymphocytic 57 cryptococcosis 57 thrombo embolic 57 Ionizing radiation 57 SOD2 gene 57 hormonally responsive 57 immune suppressive 57 pre cancerous lesion 57 recurrent prostate cancer 57 reduce serum phosphate 57 EGFR pathway 57 neuro endocrine 57 Single Nucleotide Polymorphisms SNPs 57 intraductal 57 metastatic lesion 57 trastuzumab resistant 57 clonal expansion 57 Unstable angina 57 M. ulcerans 57 hyperalgesia 57 bioprosthetic valve 57 Glioblastoma Multiforme 57 cardiac dysfunction 57 uveal melanoma 57 psoriasis Crohn disease 57 metastatic androgen independent 57 renal tumors 57 axillary lymph nodes 57 dysplastic lesions caused 57 busulfan 57 deCODE AF TM 57 aerodigestive tract 57 metastatic breast 57 minimally symptomatic 57 Genital HPV 57 raloxifene Evista 57 HDR brachytherapy 57 lymphoid cells 57 apoptosis induced 57 ImmuKnow 57 candidate TNFerade biologic 57 AA amyloidosis 57 replicon 57 pharynx larynx 57 tumor biopsies 57 thrombocytopenic 57 adjuvant cisplatin 57 impair fertility 57 alpha interferons 57 mycosis fungoides 57 HIF 1α 57 CDH1 57 PI3K/Akt pathway inhibitor 57 multiorgan 57 CyPath ® 57 metabolomic profiles 57 BCR ABL mutations 57 acute myeloid 57 AML MDS 57 thyroid carcinoma 57 Genetic mutations 57 delay bone metastases 57 Macular edema 57 extramedullary 57 doxorubicin Transdrug R 57 PITX2 methylation 57 LHRH agonists 57 Combination antiretroviral therapy 57 NKG2D 57 thetreatment 57 alkylating 57 fluoroquinolone resistance 57 HER2 positive cancers 57 Cristofanilli 57 pegnivacogin 57 chronic thromboembolic pulmonary 57 pharmacodynamic markers 57 hyperactivated 57 Proxinium TM 57 Zevalin consolidation 57 unruptured aneurysm 57 Trastuzumab DM1 57 somatic mutations 57 prolongs survival 57 BRAF V# mutation 57 repigmentation 57 malignant ascites 57 recurrent bladder 57 intravesical infusion therapy 57 ara C 57 ABCB1 57 E cadherin expression 57 PLX STROKE targeting 57 arterial calcification 57 lymph node biopsies 57 Provecta TM 57 ImmunoGen TAP technology 57 mitochondrial toxicity 57 nonalcoholic steatohepatitis NASH 57 estramustine 57 HistoScanning 57 Chronic HCV infection 57 clonogenic 57 Uncontrolled hypertension 57 cutaneous lupus 57 hematological malignancy 57 metastatic cancers 57 familial pancreatic cancer 57 pleural fluid 57 Moraxella bovis 57 murine models 57 bone marrow lymph nodes 57 haematopoietic stem cell 57 refractory colorectal cancer 57 Ph + acute lymphoblastic 57 Taxotere docetaxel 57 multivessel coronary artery 57 differential gene expression 57 smoldering myeloma 57 lesional 57 photosensitizing agent 57 Lilly Gemzar 57 adeno associated viruses 57 GnRH analogue 57 biliary tract 57 ductal lavage 57 pegylated liposomal doxorubicin 57 clade B 57 administered systemically 57 chronic hemolysis 57 debulking surgery 57 plus dacarbazine 57 EUS FNA 57 undergo prostate biopsy 57 malignant brain 57 pulmonary metastases 57 intracellular bacteria 57 r hGH 57 breast uterine 57 etiologic agent 57 ovarian bladder 57 EGFR HER2 57 deCODE Glaucoma TM 57 Genetic sequencing 57 intra abdominal abscess 57 mTOR kinase 57 hereditary deficiency 57 TOCOSOL Camptothecin 57 bioluminescent imaging 57 Tasigna prolongs 57 anticancer therapeutics 57 anaplastic astrocytoma AA 57 refractory indolent non 57 vincristine sulfate 57 MET amplification 56 epithelial ovarian 56 FGFR3 56 osteolytic bone disease 56 progesterone receptor PR 56 Enzastaurin 56 cytotoxicity assays 56 antitumor efficacy 56 Vicinium TM 56 photodynamic treatment 56 idiopathic myelofibrosis 56 chlamydial 56 surgically resectable 56 Azedra 56 peritoneal fluid 56 mammographically 56 HSPCs 56 hepatocellular cancer 56 plasma kallikrein 56 lymphovascular invasion 56 GI bleeds 56 CTAP# Capsules 56 polyps growths 56 RQ PCR 56 Arranon 56 DCVax Brain 56 Apaziquone 56 HER2 positive metastatic 56 gemcitabine cisplatin 56 CTLA4 Ig 56 Estrogen Receptor 56 adenomatous 56 Virulizin ® 56 trastuzumab Herceptin ® 56 HER2 negative 56 Accelerated Partial Breast Irradiation 56 invasive ductal breast cancer 56 metaplasia 56 preoperative staging 56 INxin 56 methylation biomarkers 56 basal cell skin 56 AA Amyloidosis 56 non metastatic resectable 56 MGUS 56 inherited gene mutation 56 lymphocytic 56 gamma globin gene 56 VHL gene 56 thyroid nodules 56 catheter angiography 56 Soy isoflavones 56 HGS ETR1 mapatumumab 56 IMiDs R 56 CDDO Im 56 photosensitizing 56 GVAX Pancreas Vaccine 56 Kit CD# positive 56 bladder ovarian 56 radiotherapeutic 56 metastatic ocular 56 intestinal metaplasia 56 induced angiogenesis 56 alvespimycin 56 mitotic catastrophe 56 Ischaemic heart 56 vitamin D receptors 56 myeloablative 56 FGFR2 gene 56 metastatic tumors 56 prognostic variables 56 BRAF V#E 56 baseline LDH 56 transthyretin amyloidosis 56 hepatocellular carcinoma HCC 56 patients receiving myelosuppressive 56 biliary tree 56 thymic carcinoma 56 endometrial carcinoma 56 vascular lesion 56 candidemia 56 pretargeting 56 microtubule inhibitor 56 nonischemic 56 benign moles 56 molecular determinants 56 causal variants 56 sorafenib Nexavar ® 56 breast cancer metastasis 56 premalignant 56 sCJD 56 Fas ligand 56 tumor subtype 56 Irritable bowel syndrome IBS 56 pretreatment serum 56 efaproxiral 56 Genasense ® 56 presymptomatic 56 sputum specimens 56 PEGylated interferon 56 extracolonic 56 GNAQ 56 vaccine GMK 56 irinotecan chemotherapy 56 Bone metastases 56 thoracoscopic lobectomy 56 OPAXIO 56 indolent follicular non 56 ERBB2 56 situ LCIS 56 cardio renal 56 pharmacokinetic interactions 56 Fodosine 56 choroidal neovascularization 56 optimal dosing 56 lung ovary 56 AML acute myeloid 56 myeloproliferative 56 adjuvant radiotherapy 56 Histoplasma capsulatum 56 p# mutations 56 microsphere therapy 56 oral talactoferrin 56 trans retinoic acid ATRA